| Name | Title | Contact Details |
|---|
Stormont Vail Health is a nonprofit integrated health care system that has been serving the health care needs of northeast Kansas for more than 130 years. It is comprised of Stormont Vail Hospital, a 586-bed acute care Magnet®-designated hospital, and Cotton O`Neil Clinic, a multi-specialty physician group with more than 250 physicians. Nearly 5,000 employees provide care and support services for patients in the hospital and 35 other locations, including the Cotton O`Neil Heart Center, Cancer Center, Diabetes & Endocrinology Center, Digestive Health Center, Pediatrics clinics, 10 regional primary care clinics and six Express Care clinics. Stormont Vail Health is committed to its mission of improving the health of the community by being a national leader in providing compassionate, high-quality and efficient integrated care through collaboration that results in a healthier community. Stormont Vail Health is a member of the Mayo Clinic Care Network, a group of more than 40 health care organizations who have joined together to complement their local expertise with the knowledge and experience of Mayo Clinic health care professionals. Stormont Vail`s local partnerships include housing the Bachelor of Science in Nursing program of the Baker University School of Nursing, providing athletic training services to Washburn University Athletics and being a founding partner of the Powercat Health Partnership with Kansas State University and the Kansas Health Foundation.
Les Restaurants Pacini is a La Prairie, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nuvem integrates comprehensive and compliant pharmacy solutions with clinical care to increase access to affordable drugs, improve patient outcomes, and optimize financial results for healthcare providers.
MedPoint is focused on innovative, high-value services. We are a global best-in-class company in our service areas. We work with clients on new approaches to training, education and communications that work in the real world of medicine.
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.